Projects
HYQVIA for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy, USA
HYQVIA® (immune globulin infusion 10%) is a liquid medicine that combines immune globulin infusion at a 10% concentration with the …
Vabysmo (faricimab-svoa) for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema
Vabysmo™ (faricimab-svoa) is a bispecific antibody indicated for the treatment of adult patients with neovascular (wet) age-related macular degeneration (nAMD), …
Phesgo for the Treatment of HER2-Positive Breast Cancer, US
Phesgo is a fixed-dose combination (FDC) of Perjeta and Herceptin with hyaluronidase for the treatment of human epidermal growth factor …
Sativex (Nabiximols) for the Treatment of Multiple Sclerosis, Europe
Sativex®, also known as Nabiximols, is an oromucosal spray comprising two chemical extracts - active cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) …
Veopoz for the Treatment of Chaple Disease, US
Veopoz (pozelimab) is a complement inhibitor indicated for the treatment of adult and paediatric patients aged one and older with …
Stelara for the Treatment of Moderate to Severe Crohn’s Disease, US
Developed by Janssen Biotech, Stelara is a biologic therapy indicated for the treatment of multiple indications, including moderate to severely …
NGENLA (somatrogon) for the Treatment of Paediatric Growth Hormone Deficiency, USA
NGENLA® (somatrogon) is a once-weekly, long-acting therapy created using recombinant technology for paediatric patients aged three years and older, who …
SPINRAZA for the Treatment of Spinal Muscular Atrophy, US
SPINRAZA is the first approved treatment for spinal muscular atrophy (SMA) in paediatric and adult patients. It was originally developed by …
TALVEY for the Treatment of Multiple Myeloma, US
TALVEY is indicated as a monotherapy for adults with relapsed or refractory multiple myeloma (RRMM) who have received at least …
Trodelvy (sacituzumab govitecan) for the Treatment of Advanced Triple-Negative Breast Cancer
Trodelvy (sacituzumab govitecan-hziy) is the first approved antibody-drug conjugate for the treatment of advanced triple-negative breast cancer (TNBC) in adult …
FRUZAQLA (fruquintinib) for the Treatment of Metastatic Colorectal Cancer, USA
FRUZAQLA™ (fruquintinib) is a kinase inhibitor indicated to treat adults with metastatic colorectal cancer (mCRC). It is an oral treatment designed …
Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer
Lonsurf (trifluridine and tipiracil) is an oral anti-cancer drug indicated for the treatment of patients with advanced metastatic colorectal cancer …
LUMAKRAS (sotorasib) for the Treatment of Non-Small Cell Lung Cancer
Lumakras (sotorasib) is an oral, first-in-class therapy indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or …
Loqtorzi for the Treatment of Nasopharyngeal Carcinoma, US
Loqtorzi (toripalimab-tpzi) is an immuno-oncology therapy indicated in combination with cisplatin and gemcitabine combination chemotherapy for the first-line treatment of …
Evrysdi for the Treatment of Spinal Muscular Atrophy, US
Evrysdi (risdiplam) is an oral medication indicated to treat spinal muscular atrophy (SMA) in patients, including adults, children and infants …